Our latest in the Journal of Pain @TheJournal_Pain : A critical role for α7 nicotinic acetylcholine receptor signaling in myeloid lineage cells in chronic neuropathic and inflammatory pain responses
sciencedirect.com/science/ar…
Our latest paper on Aromatase inhibitors induce pain-like musculoskeletal symptoms!
bpspubs.onlinelibrary.wiley.…
Just out in @TheJournal_Pain:
“Paclitaxel-Induced Neuroinflammation After Systemic Administration in Male and Female Mice”
Paclitaxel-induced increase in neuroinflammation is time-, sex-, and tissue- dependent.
jpain.org/article/S1526-5900…
Our latest on adolescent nicotine “Adolescent nicotine exposure affects later-life nicotine reward and withdrawal in mice” with the talented graduate student @BuzziBelle
sciencedirect.com/science/ar…
Imad Damaj retweeted
Check out this #PapersoftheWeek pick from @Edaksl14 and @ELSpharma’s Pharmacological Research about psychedelics psilocybin and DOI dose-dependently reversing pain-like behaviors through serotonergic receptor activity in mouse models of chronic pain bit.ly/4l2kRAj #PRF
Check out our newest paper with the talented former Ph.D. Student @BD_Mckiver !
Astrocyte elevated gene-1 (AEG-1) in myeloid cells is a key driver for the development of chemotherapy-induced peripheral neuropathy.
sciencedirect.com/science/ar…
Just out: psychedelics in action! Our paper in collaboration with Javier Gonzalez-Maeso group and awesome members of the lab @BuzziBelle and Eda Köşeli demonstrating the long lasting effects of a single dose of psilocybin in mouse models of chronic pain.
sciencedirect.com/science/ar…
Join us on this interesting conference!
🚨 Exciting news! 🚨
We’re thrilled to announce the schedule & speaker lineup for our virtual conference on March 7, 2025! 🎉
Stay tuned for details, and get ready for an incredible event! 🔗 isrpsych.org/conferences #ISRP2025
Our new publication with some great collaborators! @SaraScienc3
“Sulfonium Moieties as Ammonium Bioisosteres: Novel Ligands for the Alpha7 Nicotinic Acetylcholine Receptor"
pubmed.ncbi.nlm.nih.gov/3982…
Imad Damaj retweeted
A new paper characterizing our novel nicotine vapor self administration mouse model alongside great scientists! @LoisAkinola @DamajLab sciencedirect.com/science/ar…
Imad Damaj retweeted
Harvard scientists are leaving academia for the private sector to fast-track biomedical breakthroughs. Michael Mina (eMed), Douglas Melton (Vertex), Stuart Schreiber (Arena Bioworks) cite funding delays & admin hurdles as key reasons. #BiomedicalResearch harvardmagazine.com/2025/01/…
Glad to be part of this interesting work!
journals.plos.org/plosone/ar…
Awesome job by Yumna, a very talented medical student. She will be a wonderful physician scientist! Thanks also to Belle @BuzziBelle, a wonderful graduate student in the lab!
Excited to share that my latest, first-author publication is now online! A huge thanks to Dr. Damaj for his mentorship and to all the contributors that helped it come together! @DamajLab
doi.org/10.1177/026988112412…
Awesome work by @mfmiles and his lab!
A recent @npp_journal is out from Mignogna, Miles, & team:
"Identification of novel genetic loci and candidate genes for progressive ethanol consumption in diversity outbred mice"
nature.com/articles/s41386-0…
Congratulations Julian! Nice work with several people in the Lab @BuzziBelle on spontaneous oxycodone withdrawal.
Happy to post my first paper in the Damaj lab @DamajLab 🍾🎊🎊
sciencedirect.com/science/ar…
Awesome study by Luda Diatchenko and @JeffreyMogil groups! Thanks for including us and @Edaksl14 @CamronBryantPhD on this interesting paper!
bjanaesthesia.org/article/S0…
Thank you @EMRumney for the interview and thank you @sejordt for alerting us on this emerging health issue.
Nicotine-like chemicals being used in vapes in the U.S. and beyond, such as 6-methyl nicotine, may be more potent and addictive than traditional nicotine.
But they can also skirt regulations designed to control nicotine products. Here's my story: reuters.com/business/healthc…










